Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2011 (26).
- Mr. Anjan Chowdhury, Mr. Tapan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Ratna Patra, all are Sponsors/Directors of the
Mr. Anjan Chowdhury, Mr. Tapan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Ratna Patra, all are Sponsors/Directors of the Company, have expressed their intention to buy 25,000 shares each in addition to their current holdings of 1,27,69,890 shares, 1,25,27,890 shares, 1,21,09,130 shares and 1,13,42,650 shares respectively at prevailing market price through Stock Exchange within 31st January, 2012.
- Following the change of denomination, normal trading of the shares of the Company will resume on 04.12.2011 after record
Following the change of denomination, normal trading of the shares of the Company will resume on 04.12.2011 after record date with new face value of Tk. 10.00 per share, market lot of 10 shares and adjusted open price of Tk. 245.10 per share.
- Mr. Tapan Chowdhury and Mr. Samuel S Chowdhury, both are Sponsors/Directors of the Company, have further reported that t
Mr. Tapan Chowdhury and Mr. Samuel S Chowdhury, both are Sponsors/Directors of the Company, have further reported that they have completed their buy of 2,500 shares each at prevailing market price through Stock Exchange as announced earlier.
- Mrs. Ratna Patra and Mr. Anjan Chowdhury, both are Sponsors/Directors of the Company, have further reported that they ha
Mrs. Ratna Patra and Mr. Anjan Chowdhury, both are Sponsors/Directors of the Company, have further reported that they have completed their buy of 2,500 shares each at prevailing market price through Stock Exchange as announced earlier.
- Mr. Tapan Chowdhury, Mrs. Ratna Patra, Mr. Samuel S Chowdhury and Mr. Anjan Chowdhury, all are Sponsors/Directors of the
Mr. Tapan Chowdhury, Mrs. Ratna Patra, Mr. Samuel S Chowdhury and Mr. Anjan Chowdhury, all are Sponsors/Directors of the Company, have reported their intention to buy 2,500 shares each at prevailing market price through Stock Exchange within next 30 working days.
- (Continuation of news of SQURPHARMA-H/Y): Again, as per un-audited half yearly accounts as on 30.09.11 ((April' 11 to Se
(Continuation of news of SQURPHARMA-H/Y): Again, as per un-audited half yearly accounts as on 30.09.11 ((April' 11 to Sep' 11), the Company has reported profit after tax of Tk. 1,751.73 million with EPS of Tk. 66.14 as against Tk. 1,498.81 million and Tk. 56.59 respectively for the same period of the previous year. Whereas profit after tax was Tk. 948.73 million with EPS of Tk. 35.82 for the period of 3 months (July' 11 to Sep' 11) ended on 30.09.11 as against Tk. 776.72 million and Tk. 29.33 respectively for the same period of the previous year.
The first part of this announcement is missing from the archive. - (H/Y): As per un-audited half yearly accounts as on 30.09.11 (April' 11 to Sep' 11), the Company has reported consolidat
(H/Y): As per un-audited half yearly accounts as on 30.09.11 (April' 11 to Sep' 11), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 2,023.12 million with consolidated EPS of Tk. 76.39 as against Tk. 1,810.39 million and Tk. 68.36 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 1,048.32 million with consolidated EPS of Tk. 39.58 for the period of 3 months (July' 11 to Sep' 11) ended on 30.09.11 as against Tk. 910.11 million and Tk. 34.37 respectively for the same period of the previous year. (cont.)
- Normal trading of the shares of the Company will resume on 26.10.11 after record date for EGM.
Normal trading of the shares of the Company will resume on 26.10.11 after record date for EGM.
- Trading of the shares of the Company will remain suspended on record date i.e., 25.10.11 for EGM.
Trading of the shares of the Company will remain suspended on record date i.e., 25.10.11 for EGM.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle from 20.10.11 to 24.10.11. Trading of the shares of the Company will remain suspended on record date i.e., 25.10.11 for EGM.
- The Company has informed that the Board of Directors of the Company has decided to convene an EGM of the Shareholders to
The Company has informed that the Board of Directors of the Company has decided to convene an EGM of the Shareholders to accord approval for the following matters: (1) restructuring the par value of shares from Tk. 100.00 to Tk. 10.00 each, (2) determining the market lot of the shares from present 1 share to 50 shares and (3) merger of Square Cephalosporins Ltd. with the Square Pharmaceuticals Ltd. Date of EGM: 16.11.2011, Time: 10:30 AM, Venue: Factory Premises, Kaliakoir, Gazipur. Record date for EGM: 25.10.2011.
- The Company has informed that it has credited the Bonus shares for the year 2010-2011 to the respective shareholders' BO
The Company has informed that it has credited the Bonus shares for the year 2010-2011 to the respective shareholders' BO Accounts on 28.09.11.
- Mr. Samson H Chowdhury, Mr. Tapan Chowdhury, Mrs. Ratna Patra, Mr. Anjan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Anit
Mr. Samson H Chowdhury, Mr. Tapan Chowdhury, Mrs. Ratna Patra, Mr. Anjan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Anita Chowdhury, all are the Sponsors/Directors of the Company, have further reported that they have completed their receive of 9,70,133 shares, 68,250 shares, 62,075 shares, 69,875 shares, 66,300 shares and 1,20,979 shares respectively from Anita & Samson Foundation by way of transfer (revert back) outside the trading system of the Exchange as announced earlier.
- Mr. Samson H Chowdhury, Mr. Tapan Chowdhury, Mrs. Ratna Patra, Mr. Anjan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Anit
Mr. Samson H Chowdhury, Mr. Tapan Chowdhury, Mrs. Ratna Patra, Mr. Anjan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Anita Chowdhury, all are the Sponsors/Directors of the Company, have reported their intention to receive 9,70,133 shares, 68,250 shares, 62,075 shares, 69,875 shares, 66,300 shares and 1,20,979 shares respectively from Anita & Samson Foundation by way of transfer (revert back) outside the trading system of the Exchange within 30 working days from the date of issuance of approval letter by SEC.
- The Company has informed that the Board of Directors of the company has approved an agreement with M/s. Beacon Pharmaceu
The Company has informed that the Board of Directors of the company has approved an agreement with M/s. Beacon Pharmaceuticals Ltd. for toll manufacturing of a product on behalf of Square Pharmaceuticals Ltd. to meet the demand of the product in the market.
- Normal trading of the shares of the company will resume on 17.08.11 after record date.
Normal trading of the shares of the company will resume on 17.08.11 after record date.
- Trading of the shares of the company will remain suspended on record date i.e., 16.08.11.
Trading of the shares of the company will remain suspended on record date i.e., 16.08.11.
- (continuation of news of SQURPHARMA- Q1): Whereas, profit after tax was Tk. 802.99 million with basic EPS of Tk. 40.93 f
(continuation of news of SQURPHARMA- Q1): Whereas, profit after tax was Tk. 802.99 million with basic EPS of Tk. 40.93 for the 1st quarter ended on 30th June 2011 (Apr'11 to June'11) as against Tk. 722.09 million and Tk. 36.81 respectively for the same period of the previous year. However, considering proposed bonus share @ 35% for the year 2011, restated basic EPS will be Tk. 30.32 as on 30.06.11 and Tk. 27.27 as on 30.06.10.
The first part of this announcement is missing from the archive. - (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2011 (Apr'11 to June'11), the Company
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2011 (Apr'11 to June'11), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 974.80 million with consolidated basic EPS of Tk. 49.69 as against Tk. 900.28 million and Tk. 45.89 respectively for the same period of the previous year. However, considering proposed bonus share @ 35% for the year 2011, consolidated restated basic EPS will be Tk. 36.81 as on 30.06.11 and Tk. 33.99 as on 30.06.10. (continue)
- Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 10.08.11 to 14.08.11. Trading of the shares of the company will remain suspended on record date i.e., 16.08.11.
- There will be no price limit on the trading of the shares of the company today (24.07.11) following its corporate declar
There will be no price limit on the trading of the shares of the company today (24.07.11) following its corporate declaration.
- The Board of Directors has recommended cash dividend @ 30% and stock dividend @ 35% for the year ended on March 31, 2011
The Board of Directors has recommended cash dividend @ 30% and stock dividend @ 35% for the year ended on March 31, 2011. Date of AGM: 21.09.11, Time: 11:00 AM, Venue: Factory premises, Kaliakoir, Gazipur. Record Date: 16.08.11. The company has also reported NAV of Tk. 13,817.71 million, EPS of Tk. 129.07 and NOCFPS of Tk. 146.98 for the year ended on March 31, 2011.
- As per regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of Board of Directors of the Co
As per regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of Board of Directors of the Company will be held on July 21, 2011 at 3:30 p.m. to consider, among others, its accounts for the year ended on March 31, 2011.
- (continuation of news of SQURPHARMA-Q3 ) Again, As per un-audited quarterly accounts for the 3rd quarter ended on 31st D
(continuation of news of SQURPHARMA-Q3 ) Again, As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2010 (April'10 to Dec'10), the company has also reported net profit after tax of Tk. 2,182.54 million with EPS of Tk. 111.26 as against Tk. 1,749.61 million and Tk. 89.19 (restated) respectively for the same period of the previous year. Whereas net profit after tax was Tk. 683.73 million with EPS of Tk. 34.85 for the period of 3 months (Oct' 10 to Dec' 10) ended on 31.12.10 as against Tk. 469.40 million and Tk. 23.93 (restated) respectively for the same period of the previous year.
The first part of this announcement is missing from the archive. - (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2010 (April'10 to Dec'10), the com
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2010 (April'10 to Dec'10), the company has reported consolidated net profit after tax and minority interest of Tk. 2,660.74 million with consolidated EPS of Tk. 135.63 as against Tk. 1,995.57 million and Tk. 101.72 (restated) respectively for the same period of the previous year. Whereas consolidated net profit after tax and minority interest was Tk. 850.35 million with consolidated EPS of Tk. 43.35 for the period of 3 months (Oct' 10 to Dec' 10) ended on 31.12.10 as against Tk. 604.65 million and Tk. 30.82 (restated) respectively for the same period of the previous year. (continue)
- Mr. Dabiruddin Ahmed, one of the Sponsors of the company, has reported his intention to transfer 5,000 shares out of his
Mr. Dabiruddin Ahmed, one of the Sponsors of the company, has reported his intention to transfer 5,000 shares out of his total holdings of 3,70,813 shares to Mr. Samson H Chowdhury (another Sponsors of the company) by way of gift outside the trading system of the Exchange within next 30 working days.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.